Bioanalysis is a critical part of the discovery and development of peptide therapeutics. In this In the Zone, we explore key bioanalytical challenges of peptide bioanalysis sample preparation.
Browsing: In the Zone
Antibody–drug conjugates (ADCs) combine the best of two modalities: toxic efficacy and antibody specificity. This infographic describes various mass spectrometry-based strategies Frontage have successfully applied in the bioanalysis of ADCs for clinical and preclinical studies.
In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.
Discover more about the development of CAR-T cell therapies, their bioanalytical challenges and specialized antibody reagents that can be ustilized to overcome these in this interview with Michael Schwenkert (Bio-Rad Laboratories; Germany).
Find out more about setting up and running any flow cytometry assay with this helpful infographic including the different platforms, instrumentation, data analysis software and example assay types.